These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7248023)

  • 21. [Value of ethionamide in anti-leprosy therapy].
    Floch H; Rist N; Jacobi JC
    Bull Soc Pathol Exot Filiales; 1966; 59(5):715-24. PubMed ID: 6014273
    [No Abstract]   [Full Text] [Related]  

  • 22. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
    Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
    Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A new plan in the campaign against leprosy in Anjouan. Preliminary results].
    Grillone S; Pattyn SR
    Acta Leprol; 1986; 4(4):453-60. PubMed ID: 3296616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How effective is monthly rifampin?
    Levy L
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):629-31. PubMed ID: 8151196
    [No Abstract]   [Full Text] [Related]  

  • 25. Activity of rifampin in infections of normal mice with Mycobacterium leprae.
    Grosset JH; Guelpa-Lauras CC
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):847-51. PubMed ID: 3437168
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug resistance and multi-drug therapy in leprosy.
    Chatterjee BR
    Indian J Lepr; 1989 Jul; 61(3):328-32. PubMed ID: 2768881
    [No Abstract]   [Full Text] [Related]  

  • 27. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Problems of leprosy relapse in China.
    Li HY
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):1-7. PubMed ID: 8326169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of multidrug therapy on the treatment and control of leprosy.
    Gilbody JS
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):458-78. PubMed ID: 1890370
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental chemotherapy in leprosy, then and now.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1973; 41(3):307-19. PubMed ID: 4136732
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide.
    Winsley BE; McDougall AC; Brown KE
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):592-4. PubMed ID: 6686974
    [No Abstract]   [Full Text] [Related]  

  • 32. Lactate dehydrogenase isoenzymes in leprosy patients on multi drug therapy--a preliminary report.
    Dhandayuthapani S; Bhatia VN
    Indian J Lepr; 1988 Apr; 60(2):196-201. PubMed ID: 3192968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leprosy control based on multi drug treatment in India.
    Rao CK; Mittal BN; Dharmshaktu NS
    Indian J Lepr; 1988 Apr; 60(2):290-302. PubMed ID: 3192979
    [No Abstract]   [Full Text] [Related]  

  • 34. Comments on an editorial by B. R. Chatterjee "On Multi-Drug Combinations in the Treatment of Leprosy".
    Grosset JH; Baohang J; Noordeen SK
    Indian J Lepr; 1989 Jul; 61(3):323-7. PubMed ID: 2768880
    [No Abstract]   [Full Text] [Related]  

  • 35. [Combination drug therapy in leprosy].
    Terencio de las Aguas J
    Acta Leprol; 1983; 1(3):143-50. PubMed ID: 6359802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-drug therapy in bacilliferous leprosy--two years experience.
    Kaur S; Sharma VK; Kumar B; Singh M; Kaur I
    Indian J Lepr; 1985; 57(3):483-90. PubMed ID: 3831085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
    Pattyn S; Grillone S
    Lepr Rev; 2002 Sep; 73(3):245-7. PubMed ID: 12449889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of lepromatous leprosy by ethionamide].
    Rollier R; Rollier M
    Maroc Med; 1972 Mar; 52(555):148-66. PubMed ID: 4261347
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
    Reyes-Javier PD; Tantiongco PR
    Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
    [No Abstract]   [Full Text] [Related]  

  • 40. Follow-up study of pauci-bacillary leprosy on-multi-drug regimen.
    Ramanan R; Manglani PR; Ghorpade A; Bhagoliwal SK
    Indian J Lepr; 1987; 59(1):50-3. PubMed ID: 3611861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.